DeningTR, BerriosGE: Wilson's disease: A longitudinal study of psychiatric symptoms. Biol Psychiatry, 28:255–265, 1990.
8.
European Association for Study of Liver: EASL clinical practice guidelines: Wilson's disease. J Hepatol, 56:671–685, 2012.
9.
GromadzkaG, et al.: Middle-aged heterozygous carriers of Wilson's disease do not present with significant phenotypic deviations related to copper metabolism. J Genet, 89:463–467, 2010.
10.
HusterD: Wilson disease. Best Pract Res Clin Gastroenterol, 24:531–539, 2010.
11.
KulaksizogluIB, PolatA: Quetiapine for mania with Wilson's disease. Psychosomatics, 44:438–439, 2003.
12.
ModaiI, et al.: Penicillamine therapy for schizophreniform psychosis in Wilson's disease. J Nerv Ment Dis, 173:698–701, 1985.
13.
RobertsEA, SchilskyML: American Association for Study of Liver Diseases (AASLD)–Diagnosis and treatment of Wilson disease: An update. Hepatology, 47:2089–2111, 2008.
ThomasGR, et al.: The Wilson disease gene: Spectrum of mutations and their consequences. Nat Genet, 9:210–217, 1995.
16.
WiggelinkhuizenM, et al.: Systematic review: Clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther, 29:947–958, 2009.
17.
ZimbreanPC, SchilskyML: Psychiatric aspects of Wilson disease: A review. Gen Hosp Psychiatry, 36:53–62, 2014.
18.
ZimbreanPC, SchilskyML: The spectrum of psychiatric symptoms in Wilson's disease: Treatment and prognostic considerations. Am J Psychiatry, 172:1068–1072, 2015.
